Foghorn Therapeutics Hosts Webinar for Research & Development Day June 15th – BioSpace
Foghorn Therapeutics to host Webinar for Research & Development Day on June 15th BioSpace
Browsing Tag
BioSpace
Flare Therapeutics is starting Series A funding of $ 82 million to advance its precision oncology…
Flare Therapeutics is starting Series A funding of $ 82 million to advance its precision oncology pipeline based on BioSpace's novel approach to transcription factor drug discovery
RedHill Biopharma’s Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB Review with…
RedHill Biopharma's COVID-19 Phase 2/3 study of opaganib passes fourth DSMB review with unanimous recommendation to continue BioSpace